We did not select SK-BR-3 or BT-474 human BC cells as a HER2-positive tumor cell type because SK-BR-3 cells are poorly tumorigenic22 and SK-BR-3 and BT-474 cells coexpress EGFR at moderate or low levels, respectively.23 This evidence concerns the gene EGFR and neoplasm.